These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 19458171)

  • 61. HIV-1 Vpr reactivates latent HIV-1 provirus by inducing depletion of class I HDACs on chromatin.
    Romani B; Kamali Jamil R; Hamidi-Fard M; Rahimi P; Momen SB; Aghasadeghi MR; Allahbakhshi E
    Sci Rep; 2016 Aug; 6():31924. PubMed ID: 27550312
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Modulation of apoptosis and viral latency - an axis to be well understood for successful cure of human immunodeficiency virus.
    Timilsina U; Gaur R
    J Gen Virol; 2016 Apr; 97(4):813-824. PubMed ID: 26764023
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Vpr-GFP virion particle identifies HIV-infected targets and preserves HIV-1Vpr function in macrophages and T-cells.
    Muthumani K; Montaner LJ; Ayyavoo V; Weiner DB
    DNA Cell Biol; 2000 Mar; 19(3):179-88. PubMed ID: 10749170
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Structure of HIV-1 Vpr in complex with the human nucleotide excision repair protein hHR23A.
    Byeon IL; Calero G; Wu Y; Byeon CH; Jung J; DeLucia M; Zhou X; Weiss S; Ahn J; Hao C; Skowronski J; Gronenborn AM
    Nat Commun; 2021 Nov; 12(1):6864. PubMed ID: 34824204
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Genome-wide transcriptional profiling reveals that HIV-1 Vpr differentially regulates interferon-stimulated genes in human monocyte-derived dendritic cells.
    Zahoor MA; Xue G; Sato H; Aida Y
    Virus Res; 2015 Oct; 208():156-63. PubMed ID: 26116899
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Human immunodeficiency virus type 1 Vpr: oligomerization is an essential feature for its incorporation into virus particles.
    Venkatachari NJ; Walker LA; Tastan O; Le T; Dempsey TM; Li Y; Yanamala N; Srinivasan A; Klein-Seetharaman J; Montelaro RC; Ayyavoo V
    Virol J; 2010 Jun; 7():119. PubMed ID: 20529298
    [TBL] [Abstract][Full Text] [Related]  

  • 67. HIV-1 Vpr Functions in Primary CD4
    Vanegas-Torres CA; Schindler M
    Viruses; 2024 Mar; 16(3):. PubMed ID: 38543785
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The immunosuppressive properties of the HIV Vpr protein are linked to a single highly conserved residue, R90.
    Tcherepanova I; Starr A; Lackford B; Adams MD; Routy JP; Boulassel MR; Calderhead D; Healey D; Nicolette C
    PLoS One; 2009 Jun; 4(6):e5853. PubMed ID: 19516896
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Extracellular human immunodeficiency virus type 1 viral protein R causes reductions in astrocytic ATP and glutathione levels compromising the antioxidant reservoir.
    Ferrucci A; Nonnemacher MR; Cohen EA; Wigdahl B
    Virus Res; 2012 Aug; 167(2):358-69. PubMed ID: 22691542
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Proteolytic cleavage of HIV-1 GFP-Vpr fusions at novel sites within virions and living cells: concerns for intracellular trafficking studies.
    Caly L; Jans DA; Piller SC
    J Fluoresc; 2009 May; 19(3):567-73. PubMed ID: 19067127
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Peptides derived from the C-terminal domain of HIV-1 Viral Protein R in lipid bilayers: Structure, membrane positioning and gene delivery.
    Marquette A; Leborgne C; Schartner V; Salnikov E; Bechinger B; Kichler A
    Biochim Biophys Acta Biomembr; 2020 Feb; 1862(2):183149. PubMed ID: 31816324
    [TBL] [Abstract][Full Text] [Related]  

  • 72. HIV-1 Vpr modulates macrophage metabolic pathways: a SILAC-based quantitative analysis.
    Barrero CA; Datta PK; Sen S; Deshmane S; Amini S; Khalili K; Merali S
    PLoS One; 2013; 8(7):e68376. PubMed ID: 23874603
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Delineating HIV-associated neurocognitive disorders using transgenic models: the neuropathogenic actions of Vpr.
    Power C; Hui E; Vivithanaporn P; Acharjee S; Polyak M
    J Neuroimmune Pharmacol; 2012 Jun; 7(2):319-31. PubMed ID: 21918813
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Extracellular HIV-1 viral protein R affects astrocytic glyceraldehyde 3-phosphate dehydrogenase activity and neuronal survival.
    Ferrucci A; Nonnemacher MR; Wigdahl B
    J Neurovirol; 2013 Jun; 19(3):239-53. PubMed ID: 23728617
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Short Communication: A Quantitative System for Monitoring Blood-Circulating Viral Protein R of Human Immunodeficiency Virus-1 Detected a Possible Link with Pathogenic Indices.
    Matsunaga A; Oka M; Iijima K; Shimura M; Gatanaga H; Oka S; Ishizaka Y
    AIDS Res Hum Retroviruses; 2019 Jul; 35(7):660-663. PubMed ID: 30938169
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Vipirinin, a coumarin-based HIV-1 Vpr inhibitor, interacts with a hydrophobic region of VPR.
    Ong EB; Watanabe N; Saito A; Futamura Y; Abd El Galil KH; Koito A; Najimudin N; Osada H
    J Biol Chem; 2011 Apr; 286(16):14049-56. PubMed ID: 21357691
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Identification of viral protein R of human immunodeficiency virus-1 (HIV) and interleukin-6 as risk factors for malignancies in HIV-infected individuals: A cohort study.
    Matsunaga A; Ando N; Yamagata Y; Shimura M; Gatanaga H; Oka S; Ishizaka Y
    PLoS One; 2024; 19(1):e0296502. PubMed ID: 38166062
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Deregulation of microRNAs by HIV-1 Vpr protein leads to the development of neurocognitive disorders.
    Mukerjee R; Chang JR; Del Valle L; Bagashev A; Gayed MM; Lyde RB; Hawkins BJ; Brailoiu E; Cohen E; Power C; Azizi SA; Gelman BB; Sawaya BE
    J Biol Chem; 2011 Oct; 286(40):34976-85. PubMed ID: 21816823
    [TBL] [Abstract][Full Text] [Related]  

  • 79. HIV-1 Vpr deregulates calcium secretion in neural cells.
    Rom I; Deshmane SL; Mukerjee R; Khalili K; Amini S; Sawaya BE
    Brain Res; 2009 Jun; 1275():81-6. PubMed ID: 19328187
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The influence of viral protein R amino acid substitutions on clinical outcomes in people living with HIV: A systematic review.
    Asia LK; Jansen Van Vuren E; Williams ME
    Eur J Clin Invest; 2023 May; 53(5):e13943. PubMed ID: 36579370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.